ICON is a global provider of outsourced development services

Products and services

Offering a broad range of specialised services to assist pharmaceutical, biotechnology and medical device companies to bring new treatments to market faster. Our services span the entire lifecycle of product development and can be adapted to suit small local trials or large global programs.

Facts and Figures

  • Financial information: Full year reported revenue was $2,595.8 million. Excluding the impact of ASC 606, full year revenue increased to $1,897.6 million from $1,758.4 million in 2017, an increase of 7.9%.
  • Employee numbers: ICON currently has 14,400 employees in 98 locations in 40 countries.